Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.
about
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadSubtype cross-reactive, infection-enhancing antibody responses to influenza A virusesMolecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza virusesA miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigensAvirulent Avian influenza virus as a vaccine strain against a potential human pandemic.Influenza vaccines: a moving interdisciplinary field.Heterosubtypic immunity to influenza A virus: where do we stand?Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.Cross-protection against European swine influenza viruses in the context of infection immunity against the 2009 pandemic H1N1 virus: studies in the pig model of influenza.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesBench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferretsAnalysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Targets for the induction of protective immunity against influenza a viruses.Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferretsVirus-like particles as universal influenza vaccinesCan immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?Mapping antibody epitopes of the avian H5N1 influenza virusA high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populationsSingle-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humansSerum antibody prevents lethal murine influenza pneumonitis but not tracheitis.Virus-vectored influenza virus vaccines.Identification of novel avian influenza virus derived CD8+ T-cell epitopesDistinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesAppearance and persistence of antibodies against different virus components after regular measles infections.A novel synthetic receptor-based immunoassay for influenza vaccine quantification.Biological and protective properties of immune sera directed to the influenza virus neuraminidase.Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Influenza virus neuraminidase activates latent transforming growth factor beta.Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.Biophysical and immunological studies on the differential effect of guanidine hydrochloride on type A and type B influenza viruses.A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
P2860
Q24615003-FFC387E4-EB66-494B-9FAD-8F7CA4F8D406Q26783897-7E5D258B-3DA1-4DFE-A243-A36668260157Q27485986-694BE343-F4F1-4127-9AD1-65EF57A22943Q28387782-52E37204-BEC5-4D47-A560-4A5C6995FC33Q28830491-1BCE17D8-2022-48A0-9E78-F11F752BEE0DQ30322954-C526E8F4-E40D-4E47-83B7-CFB2F0BBF7D9Q30367695-24C2E81B-321E-479A-AB7C-63E7DE6EAD62Q30370995-35CC23A6-66D4-4B11-AA20-452D6A643FB1Q30373917-D2CDC60B-0B9A-49A7-B421-271FA1A689D4Q30379517-38503459-B015-4371-A826-19A154377ACAQ30386823-EB1BE745-2E2A-4627-822C-80E4ADCF9ACBQ30389582-67A357E8-D4EF-4095-802E-565795D0B7E4Q30392305-A29CE3B7-97BC-4BC8-936C-24402430F440Q30400179-10065B4E-7AC8-4F69-A0AC-4FF2FB451064Q30408100-AE09DCA9-932A-4AC2-95A4-2084B3A3738AQ30409789-7B0F7FB6-C00C-440F-9AD8-BA169836DD67Q30413023-34169F54-1C01-4022-9500-F77AFC2CCC11Q30421558-D39F666F-9488-4D5E-953D-CB2119A2596CQ33273605-D834F3CF-F343-4A24-8381-E9FF95D40E30Q33432749-EC3DF2AD-0C17-4282-95BD-A435E2937102Q33782762-C0D62A90-3109-42E6-8EDF-F1ED541C305FQ33820732-6CD736CC-2BE9-4937-96BE-CA615DE87BF9Q33907707-6A9B4AF7-9D1F-4985-8597-4B2DB04E14C4Q34057785-A2E7E25B-B861-411C-9B6A-F163BA26FD3AQ34087792-CC6EC82C-116E-453E-A9E2-929FB17B11CCQ34092534-8DA76B30-1456-4DA6-A27B-728211D4EA3DQ34102268-8747D15B-670F-498E-824A-7468D6AFDFC3Q34182121-EE19D907-D16C-4460-9151-41B000FD487BQ34354440-CD62D8A7-7245-4981-B0B0-710E757715B7Q34476554-69271315-6060-4FD0-A29B-4B5870ADB2DEQ34592631-B016DA00-B79E-4573-8A2E-FC9C3634212EQ34991399-F77F8BCE-CAE2-436C-BB83-4F3BACEAF1D2Q35214413-31F96C0B-0128-4E83-9EC9-5F5F33DAFECCQ35235777-8BFE6550-86C7-49EC-816C-1339761675BEQ35677624-57668232-1551-4713-925E-AD984766F14EQ35826733-41BB8BC4-0BF9-4167-ACED-F5825FA2BD83Q35873608-4236CDA0-1144-4422-8A58-6B9F0FFD4A46Q36075789-1B30B656-D0CE-4EB7-8E0C-9E31D2209D7EQ36251637-87395C22-29A7-4B71-801C-971273B89209Q36251802-EA12537C-60DD-411A-A53F-D4798C1DE877
P2860
Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1968
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protective effects of specific ...... uenza virus infection of mice.
@en
Protective effects of specific ...... uenza virus infection of mice.
@nl
type
label
Protective effects of specific ...... uenza virus infection of mice.
@en
Protective effects of specific ...... uenza virus infection of mice.
@nl
prefLabel
Protective effects of specific ...... uenza virus infection of mice.
@en
Protective effects of specific ...... uenza virus infection of mice.
@nl
P2093
P2860
P1433
P1476
Protective effects of specific ...... uenza virus infection of mice.
@en
P2093
Khakpour M
Kilbourne ED
Schulman JL
P2860
P304
P407
P577
1968-08-01T00:00:00Z